BridgeBio Pharma, Inc. (BBIO)

67.56 -0.58 (-0.85%) USD  |  NASDAQ  |  Feb 23, 15:28
More

BridgeBio Pharma Beginning Cash (Quarterly)

Beginning Cash (Quarterly) Chart

View Beginning Cash (Quarterly) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Beginning Cash (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Beginning Cash (Quarterly) Range, Past 5 Years

View Beginning Cash (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Beginning Cash (Quarterly) Benchmarks

View Beginning Cash (Quarterly) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade
Cogent Biosciences, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade